Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Pradat

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Acta Ophthalmologica|March 18, 2021
A prospective multicentre study of intravitreal injections and ocular surface in 219 patients: IVIS studySarah Verrecchia, Fredéric Chiambaretta, Laurent Kodjikian, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|September 15, 2023
Diagnostic value of elevated serum angiotensin-converting enzyme and lymphopenia in patients with granulomatous hepatitisThomas El Jammal, François Dhelft, Pierre Pradat, et al.
Clinics and Research in Hepatology and Gastroenterology|March 20, 2018
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacyVictor Virlogeux, Pascale Berthillon, Isabelle Bordes, et al.
Journal of Medical Virology|June 2, 2004
The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatmentPierre Pradat, Marianne Maynard, Maria Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 1, 2018
Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with menLaurent Cotte, Eric Cua, Jacques Reynes, et al.
Plos One|February 3, 2017
Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort studyLaurent Cotte, Tristan Ferry, Pascal Pugliese, et al.
Plos One|October 22, 2015
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected PatientsIsabelle Poizot-Martin, Alissa Naqvi, Véronique Obry-Roguet, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2022
Necrotizing external otitis: analysis of relapse risk factors in 66 patients managed during a 12 year periodWilliam Danjou, Paul Chabert, Thomas Perpoint, et al.
Antiviral Research|July 20, 2011
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter studySi-Nafa Si-Ahmed, Pierre Pradat, Roeland Zoutendijk, et al.
International Journal of Cancer|September 15, 2010
Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V studyLaurent Abramowitz, Anne-Carole Jacquard, Fatiha Jaroud, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Acta Ophthalmologica|March 18, 2021
A prospective multicentre study of intravitreal injections and ocular surface in 219 patients: IVIS studySarah Verrecchia, Fredéric Chiambaretta, Laurent Kodjikian, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|September 15, 2023
Diagnostic value of elevated serum angiotensin-converting enzyme and lymphopenia in patients with granulomatous hepatitisThomas El Jammal, François Dhelft, Pierre Pradat, et al.
Clinics and Research in Hepatology and Gastroenterology|March 20, 2018
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacyVictor Virlogeux, Pascale Berthillon, Isabelle Bordes, et al.
Journal of Medical Virology|June 2, 2004
The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatmentPierre Pradat, Marianne Maynard, Maria Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 1, 2018
Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with menLaurent Cotte, Eric Cua, Jacques Reynes, et al.
Plos One|February 3, 2017
Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort studyLaurent Cotte, Tristan Ferry, Pascal Pugliese, et al.
Plos One|October 22, 2015
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected PatientsIsabelle Poizot-Martin, Alissa Naqvi, Véronique Obry-Roguet, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2022
Necrotizing external otitis: analysis of relapse risk factors in 66 patients managed during a 12 year periodWilliam Danjou, Paul Chabert, Thomas Perpoint, et al.
Antiviral Research|July 20, 2011
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter studySi-Nafa Si-Ahmed, Pierre Pradat, Roeland Zoutendijk, et al.
International Journal of Cancer|September 15, 2010
Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V studyLaurent Abramowitz, Anne-Carole Jacquard, Fatiha Jaroud, et al.
Pageof 11